Seeing Is Believing
Freeline Therapeutics Holdings Plc's activity chart (see below) currently has 15 price targets and 22 ratings on display.
Analysts average stock forecasts to be materialized ratio is 57.33% with an average time for these price targets to be met of 128.8 days.
Most recent stock forecast was given by PATRICK TRUCCHIO from HC WAINWRIGHT on 28-Nov-2023. First documented stock forecast 01-Sep-2020.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 19-May-2021
$6.5
$0.02 (0.31%)
$15
2 years 10 months 1 days ago
(28-Nov-2023)
1/5 (20%)
$0.1 (1.56%)
223
Buy Since 01-Sep-2020
$5
$-1.48 (-22.84%)
$5
2 years 11 months 11 days ago
(18-Oct-2023)
2/3 (66.67%)
$0.09 (1.83%)
22
Hold Since 01-Jun-2023
$4
$-2.48 (-38.27%)
3 years 1 months 14 days ago
(15-Aug-2023)
3/3 (100%)
$0.14 (3.63%)
108
Buy Since 01-Dec-2021
$150
4 years 1 months 18 days ago
(11-Aug-2022)
0/1 (0%)
$115.65 (336.68%)
Buy Since 01-Feb-2022
$30
$23.52 (362.96%)
4 years 7 months 28 days ago
(01-Feb-2022)
0/1 (0%)
$12 (66.67%)
What is FRLN (Freeline Therapeutics Holdings Plc) average time for price targets to be met?
Which analyst most recently updated their price target on FRLN (Freeline Therapeutics Holdings Plc)?
Which analyst has the most public recommendations on FRLN (Freeline Therapeutics Holdings Plc)?
Which analyst is the currently most bullish on FRLN (Freeline Therapeutics Holdings Plc)?
Which analyst is the currently most reserved on FRLN (Freeline Therapeutics Holdings Plc)?